Cargando…
Postpartum medical management of hypertension and risk of readmission for hypertensive complications
To compare the risk of readmission in those receiving no treatment, labetalol, nifedipine or both at hospital discharge following delivery complicated by presence of hypertension. STUDY DESIGN: Retrospective study at a single tertiary care center over a 4-year period (2017–2020). Those with peripart...
Autores principales: | Lovgren, Todd, Connealy, Brendan, Yao, Ruofan, D. Dahlke, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799030/ https://www.ncbi.nlm.nih.gov/pubmed/36511111 http://dx.doi.org/10.1097/HJH.0000000000003340 |
Ejemplares similares
-
Postpartum readmissions for hypertensive disorders in pregnancy during the COVID-19 pandemic
por: Griffin, Myah M., et al.
Publicado: (2022) -
Best Practices for Managing Postpartum Hypertension
por: Kumar, Natasha Raj, et al.
Publicado: (2022) -
Evidence-Based Cesarean Delivery for the Nonobstetrician
por: Dahlke, Joshua D., et al.
Publicado: (2015) -
Demographics and Risk Factors of Pediatric Pulmonary Hypertension Readmissions
por: Sehgal, Mukul, et al.
Publicado: (2021) -
Risk factors for 30-day readmission in adults hospitalized for
pulmonary hypertension
por: Bhattacharya, Priyanka T., et al.
Publicado: (2020)